Kit and detection method for detecting mycoplasma pneumoniae nucleic acid and drug resistance gene variation of mycoplasma pneumoniae nucleic acid
A technology of Mycoplasma pneumoniae and drug-resistant genes, applied in the field of molecular biology, can solve problems such as limited sensitivity, achieve the effect of shortening the reaction time and preventing residual pollution
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0064] Embodiments, detection kits and detection methods for Mycoplasma pneumoniae nucleic acid and the presence or absence of drug-resistant gene mutations
[0065] The wild-type base sequence of the Mycoplasma pneumoniae nucleic acid 23S rRNA gene that can be a detection object of the present invention is the base sequence shown in the sequence number 33 in the sequence listing.
[0066] The detection kit for Mycoplasma pneumoniae nucleic acid and its drug-resistant gene variation includes KOD DNA polymerase, primer MPN-F, primer MPN-R, and specific targeting fluorescent probes,
[0067] The aforementioned primer MPN-F is a continuous sequence in the base sequence shown in No. 1910 to No. 2039 of the Mycoplasma pneumoniae nucleic acid 23S rRNA gene (SEQ ID NO: 33) or in a base sequence complementary thereto and has a length of 25 to 36 A forward primer consisting of a nucleotide sequence of 1 base,
[0068] The aforementioned primer MPN-R is a continuous sequence of 25 to 3...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com